Summary
Photodynamic activation of macrophage-like cells contributes to an effective outcome of photodynamic therapy (PDT) treatment. The possibility for an enhancement of macrophage activity by photosensitization with meta-tetra(hydroxyphenyl)chlorin (mTHPC) (1 μg ml–1) was studied in U937, monocyte cell line differentiated into macrophages (U937Φ cells). Phagocytic activity of U937Φ cells was evaluated by flow-cytometry monitoring of ingestion of fluorescein-labelled Escherichia coli particles. Increase in irradiation fluence up to 3.45 mJ cm–2 (corresponding irradiation time 15 s) resulted in significant increase in fluorescence signal (145%), while at higher light fluences the signal lowered down to the untreated control values. A light energy-dependent production of tumour necrosis factor-alpha (TNF-α) by photosensitized macrophages was further demonstrated using the L929 assay. The maximum TNF-α mediated cytolysis was observed at 28 mJ cm–2 and was 1.7-fold greater than that in control. In addition, we demonstrated a fluence-dependent increase in nitric oxide (NO) production by mTHPC-photosensitized macrophages. NO release increased gradually and reached a plateau after irradiation fluence of 6.9 mJ cm–2. Cytotoxicity measurements indicated that the observed manifestations of mTHPC-photosensitized macrophage activation took place under the sublethal light doses. The relevance of the present findings to clinical mTHPC-PDT is discussed.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Adams, DO & Nathan, CF (1983). Molecular mechanisms in tumor cell killing by activated macrophages. Immunol Today 4: 166–170.
Aderka, D, Le, JM & Vilcek, J (1989). IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol 143: 3517–3523.
Albina, JE & Reichner, JS (1998). Role of nitric oxide in mediation of macrophage cytotoxicity and apoptosis. Cancer Metastas Rev 17: 39–53.
Anderson, C, Hrabovsky, S, McKinley, Y, Tubesing, K, Tang, H, Dunbar, R, Mukhtar, H & Elmets, CA (1997). Phtalocyanine photodynamic therapy: disparate effects of pharmacologic inhibitors on cutaneous photosensitivity and on tumor regression. Photochem Photobiol 65: 895–901.
Asher, A, Mule, JJ, Reichert, CM, Shiloni, E & Rosenberg, SA (1987). Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo. J Immunol 138: 963–974.
Brown, EJ (1995). Phagocytosis. BioEssays 17: 109–117.
Buettner, GR & Kelley, EE (1997). EPR detection of nitric oxide (NO) in the phototherapy of tumors. Photochem Photobiol 65: 55S
Collins, HI & Bancroft, GJ (1992). Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-α and granulocyte-macrophage colony-stimulating factor for phagocytosis of. Cryptococcus neoformans. Eur J Immunol 22: 1447–1454.
Dilkes, MG, DeJode, ML, Rowntree-Taylor, A, McGilligan, JA & Kenyon, GS McKelvie (1997). mTHPC photodynamic therapy for head and neck cancer. Lasers Med Sci 11: 23–29.
Dougherty, TJ, Gomer, CJ, Henderson, BW, Jori, G, Kessel, D, Korbelik, M, Moan, J & Peng, Q (1998). Photodynamic therapy. J Natl Cancer Inst 90: 889–905.
Evans, S, Matthews, W, Perry, R, Fraker, D, Norton, J & Pass, HI (1990). Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages. J Natl Cancer Inst 82: 34–39.
Grosjean, P, Savary, J & Wagnieres, G (1993). Tetra(m-hydroxyphenyl)chlorin clinical photodynamic therapy of early bronchial and oesophageal cancers. Lasers Med Sci 8: 235–243.
Gupta, S, Ahmad, N & Mukhtar, H (1998). Involvement of nitric oxide during phthalocyanine (Pc4) photodynamic therapy-mediated apoptosis. Cancer Res 58: 1785–1788.
Henderson, BW & Dougherty, TJ (1992). How does photodynamic therapy work?. Photochem Photobiol 55: 145–157.
Hoff, T, Spencker, T, Emmendoerffer, A & Goppelt-Struebe, M (1992). Effects of glucocorticoids on the TPA-induced monocytic differentiation. J Leukoc Biol 52: 173–182.
Korbelik, M & Krosl, G (1996). Photosensitizer distribution and photosensitized damage of tumor tissues. In: The Fundamental Bases of Phototherapy, Honigsmann H, Jori G and Young AR (eds), pp. 229–245: OEMF spa: Milan
Korbelik, M, Naraparaju, VR & Yamamoto, N (1997). Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer. Br J Cancer 75: 202–207.
Korbelik, M, Shibuya, H & Cecic, I (1998). Relevance of nitric oxide to the response of tumors to photodynamic therapy. In: Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy VII, Dougherty TJ (ed), Proceedings of SPIE 3247: 98–105
Krosl, G & Korbelik, M (1994). Potentiation of photodynamic therapy by immunotherapy: the effect of schizophyllan (SPG). Cancer Lett 84: 43–44.
Krosl, G, Korbelik, M & Dougherty, GJ (1995). Induction of cell infiltration into murine SCCVII tumor by photofrin-based photodynamic therapy. Br J Cancer 71: 549–555.
Krosl, G, Korbelik, M, Krosl, J & Dougherty, GJ (1996). Potentiation of photodynamic therapy elicited antitumor response by localized treatment with granulocyte-macrophage colony stimulating factor. Cancer Res 56: 3281–3286.
McHale, AP & McHale, L (1988). Use of tetrazolium based colorimetric assay in assessing photoradiation therapy in vitro. Cancer Lett 41: 315–321.
Merlin, JL, Azzi, S, Lignon, D, Ramacci, C, Zeghari, N & Guillemin, F (1992). MTT assay allow quick and reliable measurement of the response of human tumor cells to photodynamic therapy. Eur J Cancer 29: 1452–1458.
Nakagawa, Y, Homma, S, Yamamoto, I, Banno, M, Nakazato, H, Imanaga, H & Yamamoto, N (1993). In vivo and in vitro activation of macrophages with a cyanine photosensitizing dye, platonin. Cancer Immunol Immunother 37: 157–162.
Parkins, CS, Dennis, MF, Stratford, MRL, Hill, SA & Chaplin, DJ (1995). Ischemia reperfusion injury in tumors: the role of oxygen radicals and nitric oxide. Cancer Res 55: 6026–6029.
Pass, HI (1993). Photodynamic therapy in oncology. J Natl Cancer Inst 85: 443–456.
Ris, HB, Altermatt, HJ, Inderbitzi, R, Heiss, R, Nachbur, B, Stewart, JCM, Wang, Q, Lim, CK, Bonett, R & Althaus, U (1991). Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results. Br J Cancer 64: 1116–1120.
Sveinbjornsson, B, Olsen, R, Seternes, OM & Seljelid, R (1996). Macrophage cytotoxicity against murine Meth A sarcoma involves nitric oxide-mediated apoptosis. Biochem Biophys Res Commun 223: 643–649.
Wan, CP, Choon, SP & Lau, BHS (1993). A rapid and simple microfluorimetric phagocytosis assay. J Immunol Methods 162: 1–7.
Yamamoto, N, Homma, S, Sery, TW, Donoso, LA & Hoober, JK (1991). Photodynamic immunopotentiation: in vitro activation of macrophages by treatment of mouse peritoneal cells with hematoporphyrin derivative and light. Eur J Cancer 27: 467–471.
Yamamoto, N, Homma, S, Nakagawa, Y, Hayami, M, Imanaga, H, Kurimoto, M, Misuhashi, M & Kimoto, T (1992a). Activation of mouse macrophages by in vivo and in vitro treatment with a cyanine dye, lumin. J Photochem Photobiol B: Biol 13: 295–306.
Yamamoto, N, Hoober, K & Yamamoto, S (1992b). Tumoricidal capacities of macrophages photodynamically activated with hematoporphyrin derivative. Photochem Photobiol 56: 245–250.
Yamamoto, N, Sery, TW, Hoober, JK, Willett, NP & Lindsay, DD (1994). Effectiveness of photofrin II in activation of macrophages and in vitro killing of retinoblastoma cells. Photochem Photobiol 60: 160–164.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Coutier, S., Bezdetnaya, L., Marchal, S. et al. Foscan® (mTHPC) photosensitized macrophage activation: enhancement of phagocytosis, nitric oxide release and tumour necrosis factor-α-mediated cytolytic activity. Br J Cancer 81, 37–42 (1999). https://doi.org/10.1038/sj.bjc.6690648
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690648
Keywords
This article is cited by
-
Locoregional Therapies of Liver Metastases in a Rat CC531 Coloncarcinoma Model Results in Increased Resistance to Tumour Rechallenge
Clinical & Experimental Metastasis (2005)